Literature DB >> 11881698

Cognitive function in patients with Cushing syndrome: a longitudinal perspective.

L D Dorn1, P Cerrone.   

Abstract

The purposes of this study were to examine the level of improvement of cognitive function 12 months posttreatment in adult patients with Cushing syndrome (CS), the relationships of cognitive function to duration of CS or recovery of the hypothalamic pituitary adrenal (HPA) axis, and depression and improved cognitive functioning. Thirty-three patients with CS and a matched comparison group were enrolled. IQ, depression, and endocrine factors were measured during the active phase of CS and at 12 months posttreatment for CS. Results show no group differences in cognitive function across time but a trend for CS patients to have lower IQ scores at baseline. Individual differences in performance were striking. For some subscales of IQ there was a positive relationship with recovery of the HPA axis and a negative relationship with duration of CS as well as an improvement if depression had decreased. Limitations of the study are cited along with clinical implications and directions for future research.

Entities:  

Mesh:

Year:  2000        PMID: 11881698     DOI: 10.1177/10547730022158672

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  12 in total

Review 1.  Cushing's Syndrome in Pediatrics: An Update.

Authors:  Maya B Lodish; Margaret F Keil; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

2.  Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing's Disease.

Authors:  Steven J A van der Werff; J Nienke Pannekoek; Cornelie D Andela; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee
Journal:  Neuropsychopharmacology       Date:  2015-02-05       Impact factor: 7.853

3.  Younger age and early puberty are associated with cognitive function decline in children with Cushing disease.

Authors:  Margaret F Keil; Joo Y Kang; Aiyi Liu; Edythe A Wiggs; Deborah Merke; Constantine A Stratakis
Journal:  Clin Endocrinol (Oxf)       Date:  2021-10-19       Impact factor: 3.523

Review 4.  Psychosomatic aspects of Cushing's syndrome.

Authors:  Nicoletta Sonino; Francesco Fallo; Giovanni A Fava
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

5.  Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.

Authors:  Margaret F Keil; Alan Zametkin; Celia Ryder; Maya Lodish; Constantine A Stratakis
Journal:  Pediatrics       Date:  2016-03-29       Impact factor: 7.124

Review 6.  Quality of life and other outcomes in children treated for Cushing syndrome.

Authors:  Margaret F Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

Review 7.  Neuropsychiatric disorders in Cushing's syndrome.

Authors:  Rosario Pivonello; Chiara Simeoli; Maria Cristina De Martino; Alessia Cozzolino; Monica De Leo; Davide Iacuaniello; Claudia Pivonello; Mariarosaria Negri; Maria Teresa Pellecchia; Felice Iasevoli; Annamaria Colao
Journal:  Front Neurosci       Date:  2015-04-20       Impact factor: 4.677

8.  Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease.

Authors:  Steven J A van der Werff; Cornelie D Andela; J Nienke Pannekoek; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee
Journal:  Neuroimage Clin       Date:  2014-02-10       Impact factor: 4.881

9.  Reversible brain atrophy and cognitive impairment in an adolescent Japanese patient with primary adrenal Cushing's syndrome.

Authors:  Nobumasa Ohara; Hiroshi Suzuki; Akiko Suzuki; Masanori Kaneko; Masahiro Ishizawa; Kazuo Furukawa; Takahiro Abe; Yasuhiro Matsubayashi; Takaho Yamada; Osamu Hanyu; Takayoshi Shimohata; Hirohito Sone
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-15       Impact factor: 2.570

10.  Cushing Syndrome Associated Myopathy: It Is Time for a Change.

Authors:  Martin Reincke
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.